WallStreetZenWallStreetZen

NASDAQ: ACB
Aurora Cannabis Inc Stock

$7.38-0.23 (-3.02%)
Updated May 17, 2024
ACB Price
$7.38
Fair Value Price
N/A
Market Cap
$351.22M
52 Week Low
$2.84
52 Week High
$11.50
P/E
-1.87x
P/B
0.91x
P/S
1x
PEG
N/A
Dividend Yield
N/A
Revenue
$199.23M
Earnings
-$107.70M
Gross Margin
36.7%
Operating Margin
-46.95%
Profit Margin
-53.7%
Debt to Equity
0.5
Operating Cash Flow
-$54M
Beta
1.49
Next Earnings
Jun 12, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ACB Overview

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACB is good value based on its book value relative to its share price (0.91x), compared to the US Drug Manufacturers - Specialty & Generic industry average (2.2x)
P/B vs Industry Valuation
ACB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ACB due diligence checks available for Premium users.

Be the first to know about important ACB news, forecast changes, insider trades & much more!

ACB News

Valuation

ACB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.87x
Industry
-1.01x
Market
30.97x

ACB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.91x
Industry
2.2x
ACB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACB's financial health

Profit margin

Revenue
$48.4M
Net Income
-$19.2M
Profit Margin
-39.7%
ACB's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ACB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$614.4M
Liabilities
$194.7M
Debt to equity
0.5
ACB's short-term assets ($303.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACB's short-term assets ($303.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.0M
Investing
$5.2M
Financing
$11.4M
ACB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACB vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
ACB$351.22M-3.02%-1.87x0.91x
ORGO$363.25M-3.86%68.50x1.31x
KMDA$308.67M-1.56%21.48x1.25x
PROC$300.11M+3.10%5.12x7.62x
EBS$290.83M+5.31%-0.51x0.44x

Aurora Cannabis Stock FAQ

What is Aurora Cannabis's quote symbol?

(NASDAQ: ACB) Aurora Cannabis trades on the NASDAQ under the ticker symbol ACB. Aurora Cannabis stock quotes can also be displayed as NASDAQ: ACB.

If you're new to stock investing, here's how to buy Aurora Cannabis stock.

What is the 52 week high and low for Aurora Cannabis (NASDAQ: ACB)?

(NASDAQ: ACB) Aurora Cannabis's 52-week high was $11.50, and its 52-week low was $2.84. It is currently -35.83% from its 52-week high and 159.86% from its 52-week low.

How much is Aurora Cannabis stock worth today?

(NASDAQ: ACB) Aurora Cannabis currently has 47,590,382 outstanding shares. With Aurora Cannabis stock trading at $7.38 per share, the total value of Aurora Cannabis stock (market capitalization) is $351.22M.

Aurora Cannabis stock was originally listed at a price of $72.12 in Jul 15, 2014. If you had invested in Aurora Cannabis stock at $72.12, your return over the last 9 years would have been -89.77%, for an annualized return of -22.38% (not including any dividends or dividend reinvestments).

How much is Aurora Cannabis's stock price per share?

(NASDAQ: ACB) Aurora Cannabis stock price per share is $7.38 today (as of May 17, 2024).

What is Aurora Cannabis's Market Cap?

(NASDAQ: ACB) Aurora Cannabis's market cap is $351.22M, as of May 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aurora Cannabis's market cap is calculated by multiplying ACB's current stock price of $7.38 by ACB's total outstanding shares of 47,590,382.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.